Predictive value of preoperative alkaline phosphatase to prealbumin ratio in prognosis and postoperative complications in patients with hepatocellular carcinoma after radical tumor resection

Shengdeng CHEN; Zhiqiang MOU; Zhongyao CHEN; Jian WEN; Qiu LI

doi:10.3969/j.issn.1001-5256.2023.01.018

Volume 39 Issue 1

Jan. 2023

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(1): 118-127

PDF( 2364 KB)

Predictive value of preoperative alkaline phosphatase to prealbumin ratio in prognosis and postoperative complications in patients with hepatocellular carcinoma after radical tumor resection

DOI: 10.3969/j.issn.1001-5256.2023.01.018

Department of General Surgery (Hepatobiliary), the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China

Research funding:

Luzhou Municipal People's Government-Southwest Medical University Science and Technology Strategic Cooperation Projects (2018LZXNYD-ZK15)

More Information

Corresponding author: LI Qiu, 354145933@qq.com (ORCID: 0000-0001-5259-6449)
Received Date: 2022-06-18
Accepted Date: 2022-08-22
Published Date: 2023-01-20

Abstract

Abstract

Objective To explore the predictive value of preoperative alkaline phosphatase to prealbumin ratio (APR) in prognosis and postoperative complications for patients with hepatocellular carcinoma (HCC) after radical tumor resection. Methods A total of 217 HCC patients who underwent radical tumor resection in the Department of Hepatobiliary Surgery of the Affiliated Hospital of Southwest Medical University from January 2013 to August 2021 were retrospectively recruited and their clinical data were statistically analyzed. The X-tile software was used to obtain the optimal cutoff value of APR. The χ² test was conducted to analyze association between preoperative APR and other clinicopathological characteristics. The Kaplan-Meier curve was plotted and the Log-rank test was performed to analyze survival of patients. The univariate and multivariate Cox proportional hazards regression models were used to analysis factors affecting the prognosis of HCC patients. The univariate analysis and multivariate Logistic regression were used to identify factors related with postoperative complications. The receiver operating characteristic (ROC) curve was used to determine the predicting value of APR. Results The optimal cutoff value for APR ratio was 0.5 and these 217 patients were divided into the low- and high APR groups (111 vs 106 cases) accordingly. Compared with the low-APR group, the proportion of patients with ALT (> 50 U/L), Alb (< 40 g/L), the CNLC of the III stage, open surgery, liver cirrhosis, multiple tumor lesions, postoperative complication, and major complication were significantly increased in the high-APR patients (all P < 0.05). Moreover, the 1-, 3-, and 5-year OS were 86.0%, 74.9%, and 71.3%, respectively in the low-APR patients, while the numbers were 79.2%, 57.5%, and 47.0%, respectively, in the high-APR patients, indicating that patients in high-APR group had significantly worse OS (P=0.002). AFP (HR=1.774, 95%CI: 1.107-2.843, P=0.017), CNLC stage (HR=2.708, 95%CI: 1.514-4.844, P=0.001), tumor size (HR=1.696, 95%CI: 1.060-2.714, P=0.028), and APR (HR=2.022, 95%CI: 1.244-3.285, P=0.004) were all independent risk predictors for OS. The 1-, 3-, and 5-year RFS were 82.3%, 69.4%, and 61.3%, respectively, in the low-APR patients, whereas the numbers were 76.2%, 54.4%, and 44.2%, respectively in the high-APR patients, suggesting that high-APR patients had significantly worse recurrence-free survival (P=0.016). The CNLC stage (HR=2.509, 95%CI: 1.423-4.422, P=0.001), tumor size (HR=1.725, 95%CI: 1.119-2.660, P=0.014), and APR (HR=1.619: 95%CI: 1.037-2.527, P=0.034) were all independent FRS predictors. Hypertension (OR=3.09, 95%CI: 1.385-6.893, P=0.006), open surgery (OR=4.198, 95%CI: 1.779-9.907, P=0.001), liver cirrhosis (OR=2.376, 95%CI: 1.194-4.729, P=0.014), and APR (OR=2.151, 95%CI: 1.160-3.986, P=0.015) were all independent risk predictors for the postoperative major complications. The AUC for APR, ALP, a nd PA in predicting the major complications was 0.625 (95%CI: 0.547-0.702), 0.613 (95%CI: 0.534-0.693), and 0.554 (0.474-0.634). Conclusion Preoperative APR could be used to predict prognosis and postoperative major complications of HCC patients after radical tumor resection.
- Carcinoma, Hepatocellular,
- Alkaline Phosphatase,
- Prealbumin,
- Postoperative Complications,
- Prognosis

FullText(HTML)

References(39)

References

[1]	BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492.
[2]	ZHOU M, WANG H, ZENG X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204): 1145-1158. DOI: 10.1016/S0140-6736(19)30427-1.
[3]	CHEN W, ZHENG R, BAADE PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132. DOI: 10.3322/caac.21338.
[4]	General Office of National Health Commission. Standard for diagnosis and treatment of primary liver cancer (2022 edition)[J]. J Clin Hepatol, 2022, 38(2): 288-303. DOI: 10.3969/j.issn.1001-5256.2022.02.009. 国家卫生健康委办公厅. 原发性肝癌诊疗指南(2022年版)[J]. 临床肝胆病杂志, 2022, 38(2): 288-303. DOI: 10.3969/j.issn.1001-5256.2022.02.009.
[5]	XU XF, XING H, HAN J, et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China[J]. JAMA Surg, 2019, 154(3): 209-217. DOI: 10.1001/jamasurg.2018.4334.
[6]	DHIR M, MELIN AA, DOUAIHER J, et al. A review and update of treatment options and controversies in the management of hepatocellular carcinoma[J]. Ann Surg, 2016, 263(6): 1112-1125. DOI: 10.1097/SLA.0000000000001556.
[7]	AMISAKI M, SAITO H, TOKUYASU N, et al. Prognostic value of postoperative complication for early recurrence after curative resection of hepatocellular carcinoma[J]. Hepatobiliary Pancreat Dis Int, 2018, 17(4): 323-329. DOI: 10.1016/j.hbpd.2018.03.016.
[8]	YANG T, ZHANG J, LU JH, et al. Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases[J]. World J Surg, 2011, 35(9): 2073-2082. DOI: 10.1007/s00268-011-1161-0.
[9]	CHOK KS, NG KK, POON RT, et al. Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma[J]. Br J Surg, 2009, 96(1): 81-87. DOI: 10.1002/bjs.6358.
[10]	HARIMOTO N, SHIRABE K, IKEGAMI T, et al. Postoperative complications are predictive of poor prognosis in hepatocellular carcinoma[J]. J Surg Res, 2015, 199(2): 470-477. DOI: 10.1016/j.jss.2015.06.012.
[11]	THELEN A, BENCKERT C, TAUTENHAHN HM, et al. Liver resection for hepatocellular carcinoma in patients without cirrhosis[J]. Br J Surg, 2013, 100(1): 130-137. DOI: 10.1002/bjs.8962.
[12]	LI Y, WANG JS, GUO Y, et al. Use of the alkaline phosphatase to prealbumin ratio as an independent predictive factor for the prognosis of gastric cancer[J]. World J Gastroenterol, 2020, 26(44): 6963-6978. DOI: 10.3748/wjg.v26.i44.6963.
[13]	RAHBARI NN, GARDEN OJ, PADBURY R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS)[J]. Surgery, 2011, 149(5): 713-724. DOI: 10.1016/j.surg.2010.10.001.
[14]	DINDO D, DEMARTINES N, CLAVIEN PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey[J]. Ann Surg, 2004, 240(2): 205-213. DOI: 10.1097/01.sla.0000133083.54934.ae.
[15]	CLAVIEN PA, BARKUN J, de OLIVEIRA ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience[J]. Ann Surg, 2009, 250(2): 187-196. DOI: 10.1097/SLA.0b013e3181b13ca2.
[16]	HAARHAUS M, BRANDENBURG V, KALANTAR-ZADEH K, et al. Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD[J]. Nat Rev Nephrol, 2017, 13(7): 429-442. DOI: 10.1038/nrneph.2017.60.
[17]	PARK JB, KANG DY, YANG HM, et al. Serum alkaline phosphatase is a predictor of mortality, myocardial infarction, or stent thrombosis after implantation of coronary drug- eluting stent[J]. Eur Heart J, 2013, 34(12): 920-931. DOI: 10.1093/eurheartj/ehs419.
[18]	LI JP, XU T, YANG FC, et al. Prognostic value of APAR for patients with hepatocellular carcinoma after radical hepatectomy[J/CD]. Chin J Hepat Surg(Electronic Edition), 2021, 10(3): 279-284. DOI: 10.3877/cma.j.issn.2095-3232.2021.03.010. 李蒋鹏, 徐婷, 杨发才, 等. APAR对肝细胞癌根治性切除术后患者预后的预测价值[J/CD]. 中华肝脏外科手术学电子杂志, 2021, 10(3): 279-284. DOI: 10.3877/cma.j.issn.2095-3232.2021.03.010.
[19]	BARGER A, BAKER K, DRISKELL E, et al. The use of alkaline phosphatase and runx2 to distinguish osteosarcoma from other common malignant primary bone tumors in dogs[J]. Vet Pathol, 2022, 59(3): 427-432. DOI: 10.1177/03009858221083035.
[20]	YANG Y, ZHANG M, ZHANG W, et al. Sensitive sensing of alkaline phosphatase and γ-glutamyltranspeptidase activity for tumor imaging[J]. Analyst, 2022, 147(8): 1544-1550. DOI: 10.1039/d2an00163b.
[21]	XIA F, NDHLOVU E, LIU Z, et al. Alpha-fetoprotein+alkaline phosphatase (A-A) score can predict the prognosis of patients with ruptured hepatocellular carcinoma underwent hepatectomy[J]. Dis Markers, 2022, 2022: 9934189. DOI: 10.1155/2022/9934189.
[22]	ZHANG K, DONG S, JING YH, et al. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis[J]. BMC Cancer, 2020, 20(1): 541. DOI: 10.1186/s12885-020-07023-9.
[23]	ZHOU S, JIANG W, WANG H, et al. Predictive value of pretreatment albumin-to-alkaline phosphatase ratio for overall survival for patients with advanced non-small cell lung cancer[J]. Cancer Med, 2020, 9(17): 6268-6280. DOI: 10.1002/cam4.3244.
[24]	CHEN XY, LAN M, ZHOU Y, et al. Risk factors for bone metastasis from renal cell cancer[J]. J Bone Oncol, 2017, 9: 29-33. DOI: 10.1016/j.jbo.2017.10.004.
[25]	SMITH SH. Using albumin and prealbumin to assess nutritional status[J]. Nursing, 2017, 47(4): 65-66. DOI: 10.1097/01.NURSE.0000511805.83334.df.
[26]	DELLIÈRE S, CYNOBER L. Is transthyretin a good marker of nutritional status?[J]. Clin Nutr, 2017, 36(2): 364-370. DOI: 10.1016/j.clnu.2016.06.004.
[27]	BECK FK, ROSENTHAL TC. Prealbumin: a marker for nutritional evaluation[J]. Am Fam Physician, 2002, 65(8): 1575-1578.
[28]	SHEN Z, ZHANG J, ZHAO S, et al. Preoperative biliary drainage of severely obstructive jaundiced patients decreases overall postoperative complications after pancreaticoduodenectomy: A retrospective and propensity score- matched analysis[J]. Pancreatology, 2020, 20(3): 529-536. DOI: 10.1016/j.pan.2020.02.002.
[29]	LOFTUS TJ, BROWN MP, SLISH JH, et al. Serum levels of prealbumin and albumin for preoperative risk stratification[J]. Nutr Clin Pract, 2019, 34(3): 340-348. DOI: 10.1002/ncp.10271.
[30]	HUANG L, LI J, YAN JJ, et al. Prealbumin is predictive for postoperative liver insufficiency in patients undergoing liver resection[J]. World J Gastroenterol, 2012, 18(47): 7021-7025. DOI: 10.3748/wjg.v18.i47.7021.
[31]	LI JD, XU XF, HAN J, et al. Preoperative prealbumin level as an independent predictor of long-term prognosis after liver resection for hepatocellular carcinoma: a multi-institutional study[J]. HPB (Oxford), 2019, 21(2): 157-166. DOI: 10.1016/j.hpb.2018.06.1803.
[32]	CHRYSOSTOMOU S, STATHAKIS C, PETRIKKOS G, et al. Assessment of prealbumin in hemodialysis and renal-transplant patients[J]. J Ren Nutr, 2010, 20(1): 44-51. DOI: 10.1053/j.jrn.2009.04.001.
[33]	LIU F, CAI LY, ZHONG L, et al. Model for end-stage liver disease combined with serum prealbumin to predict the prognosis of patients with decompensated liver cirrhosis[J]. J Dig Dis, 2010, 11(6): 352-357. DOI: 10.1111/j.1751-2980.2010.00465.x.
[34]	ROCHE M, LAW TY, KUROWICKI J, et al. Albumin, prealbumin, and transferrin may be predictive of wound complications following total knee arthroplasty[J]. J Knee Surg, 2018, 31(10): 946-951. DOI: 10.1055/s-0038-1672122.
[35]	KALANTAR-ZADEH K, ANKER SD, HORWICH TB, et al. Nutritional and anti-inflammatory interventions in chronic heart failure[J]. Am J Cardiol, 2008, 101(11A): 89E-103E. DOI: 10.1016/j.amjcard.2008.03.007.
[36]	WEN X, YAO M, LU Y, et al. Integration of prealbumin into Child-Pugh classification improves prognosis predicting accuracy in HCC patients considering curative surgery[J]. J Clin Transl Hepatol, 2018, 6(4): 377-384. DOI: 10.14218/JCTH.2018.00004.
[37]	JIA RR, ZHONG JH, HUO RR, et al. Correlation between serum prealbumin and prognosis of patients with hepatocellular carcinoma after hepatectomy[J]. J Surg Oncol, 2019, 119(6): 794-800. DOI: 10.1002/jso.25378.
[38]	LI CX, ZHANG H, WU XF, et al. Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging[J]. Chin J Surg, 2021, 59(2): 134-143. DOI: 10.3760/cma.j.cn112139-20200803-00605. 李长贤, 张慧, 吴晓峰, 等. 不同中国肝癌分期肝癌根治性切除术后的临床效果及预后因素分析[J]. 中华外科杂志, 2021, 59(2): 134-143. DOI: 10.3760/cma.j.cn112139-20200803-00605.
[39]	KIM JH, KIM JW, SEO JW, et al. Noninvasive tests for fibrosis predict 5-year mortality and hepatocellular carcinoma in patients with chronic hepatitis B[J]. J Clin Gastroenterol, 2016, 50(10): 882-888. DOI: 10.1097/MCG.0000000000000574.

Relative Articles

[1]	Zhuoran LIU, Jing LI, Yu ZHOU, Pingfu XIONG, Li YANG, Wenguang FU. Value of the nomogram based on HALP score in predicting the prognosis of patients with hepatocellular carcinoma after hepatectomy[J]. Journal of Clinical Hepatology, 2023, 39(7): 1600-1608. doi: 10.3969/j.issn.1001-5256.2023.07.014
[2]	Fangfang QIAN, Meiqing DAI, Li ZHAO, Xia DENG, Ling YANG, Jue JIA, Jifang WANG, Dong WANG, Guoyue YUAN. Association between serum alkaline phosphatase and type 2 diabetes mellitus with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2023, 39(1): 83-88. doi: 10.3969/j.issn.1001-5256.2023.01.013
[3]	Jing LU, Yamin ZHANG, Hua LI, Yan MIAO. Value of a scoring system based on the serum levels of alpha-fetoprotein and alkaline phosphatase in predicting the prognosis of patients with resectable hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2023, 39(3): 599-605. doi: 10.3969/j.issn.1001-5256.2023.03.017
[4]	Qian CHEN, Huihua YAO, Bo LI. Influence of serum heat shock protein 90α on the prognosis of patients with hepatocellular carcinoma after transarterial chemoembolization[J]. Journal of Clinical Hepatology, 2022, 38(3): 577-581. doi: 10.3969/j.issn.1001-5256.2022.03.016
[5]	Guanqun SUN, Silei ZHOU, Tanlun ZENG, Junyu LIU, Xijun LIANG, Zhuo CHENG. Expression of calcitonin gene-related peptide-receptor component protein in hepatocellular carcinoma and its association with prognosis[J]. Journal of Clinical Hepatology, 2022, 38(6): 1328-1333. doi: 10.3969/j.issn.1001-5256.2022.06.021
[6]	Yong ZHANG, Zhengfa MAO. Association of tuberous sclerosis gene 1/2 mutations with the progression of hepatocellular carcinoma and prognosis[J]. Journal of Clinical Hepatology, 2021, 37(1): 84-88. doi: 10.3969/j.issn.1001-5256.2021.01.017
[7]	Weiming YU, Wenqian HONG, Binglun SUN, Jingzhao HAN, Hongfang TUO. Value of albumin-bilirubin grade in predicting liver function changes and prognosis of hepatocellular carcinoma patients undergoing transarterial chemoembolization: A Meta-analysis[J]. Journal of Clinical Hepatology, 2021, 37(11): 2575-2583. doi: 10.3969/j.issn.1001-5256.2021.11.018
[8]	Mingjun LIU, Yingjuan LIU, Gui YANG, Songmei LIU. Association of the expression of glucose-6-phosphate dehydrogenase with the prognosis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(8): 1856-1860. doi: 10.3969/j.issn.1001-5256.2021.08.021
[9]	Tao BAI, Jingli WANG, Xudong HU, Bing XIA, Hailin CHENG, Juan WANG. Association of the expression level of the long non-coding RNA TINCR in peripheral blood with Th1/Th2 balance and prognosis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2021, 37(1): 79-83. doi: 10.3969/j.issn.1001-5256.2021.01.016
[10]	Rui ZHANG, Xiujuan CHANG, Jiamin CHENG, Zhiqin ZHAO, Yinyin LI, Yinying LU, Zhen ZENG. Influence of high-density lipoprotein cholesterol on the prognosis of patients with alcohol-related hepatocellular carcinoma after radical treatment[J]. Journal of Clinical Hepatology, 2021, 37(3): 621-626. doi: 10.3969/j.issn.1001-5256.2021.03.023
[11]	Wang XinWei, Zhao ZongGang. Risk factors for infectious complications after hepatectomy in patients with intrahepatic bile duct stones[J]. Journal of Clinical Hepatology, 2017, 33(9): 1754-1757. doi: 10.3969/j.issn.1001-5256.2017.09.025
[12]	Zhu Ge, Zhao LingLing, Qian Lei, Dong YaBing, Zhao HengJun, Cui JiuWei, Wang NanYa. Influence of serum levels of alkaline phosphatase and gamma-glutamyl transpeptidase on the prognosis of patients with primary liver cancer undergoing radiofrequency ablation[J]. Journal of Clinical Hepatology, 2016, 32(12): 2342-2346. doi: 10.3969/j.issn.1001-5256.2016.12.022
[13]	Shen FeiFei, Lu LunGen. Liver alkaline phosphatase: a marker of cholestasis and bile duct injury[J]. Journal of Clinical Hepatology, 2016, 32(5): 1026-1030. doi: 10.3969/j.issn.1001-5256.2016.05.052
[14]	Zhang Yi, Yu YongSheng, Tang ZhengHao, Jiang Hong, Xi Min, Zang GuoQing. Detection of serum retinol-binding protein, pre-albumin and albumin in patients with hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2009, 25(6): 422-424.
[16]	Lu WeiYing, Sun LianNa. Clinical significance of determining serum prealbumin in patients with viral hepatitis.[J]. Journal of Clinical Hepatology, 2005, 21(1): 32-33.
[18]	Li ManNi, Zhang Fang, Su XianShi. Cloning of prealbumin cDNA and construction of the stable transfective cell line[J]. Journal of Clinical Hepatology, 2002, 18(4): 232-234.
[19]	Zhang Fang, Ceng XiaoBo, Su XianShi, Li ManNi. Significance of Assaying Serum Prealbumin in the patients with viral Hepatitis B[J]. Journal of Clinical Hepatology, 2001, 17(3): 163-164.

Supplements(0)

Cited By

Cited by

Periodical cited type(5)

1.	王婧婧，张瑜，韩振坤. 血清白蛋白/碱性磷酸酶比值对自身免疫性肝炎患者免疫抑制剂治疗效果的预测价值. 新乡医学院学报. 2025(02): 155-159 .
2.	周子涵，贾沁洁，王鹏博，崔炜. 肥厚型心肌病患者碱性磷酸酶/白蛋白比值与生存率的关系. 心肺血管病杂志. 2024(02): 151-157 .
3.	高新英，燕蕾. 术前AAPR联合CONUT评分对食管癌根治术后辅助化疗患者预后的影响. 中国医药指南. 2024(13): 1-4 .
4.	秦玉强，卢保德，宋日练，简定西，韦高猛. β2-微球蛋白、白蛋白与碱性磷酸酶比值在睾丸精原细胞瘤中的表达及临床意义. 右江民族医学院学报. 2024(02): 200-203+209 .
5.	曹莉莉，印滇. 术前白蛋白与碱性磷酸酶比值对结直肠癌根治术患者预后的预测分析. 临床血液学杂志. 2023(10): 733-737+740 .

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(3) / Tables(4)

Get Citation

PDF

XML

Article Metrics

Article views (1945) PDF downloads(100)

Predictive value of preoperative alkaline phosphatase to prealbumin ratio in prognosis and postoperative complications in patients with hepatocellular carcinoma after radical tumor resection

DOI: 10.3969/j.issn.1001-5256.2023.01.018